ACP3 LNCap clone FGC
CBP74528
询 价
索取Protocol
产品描述
产品数据库
| I. Background | |
| ACP3 (ACPP/PAP) 全称前列腺酸性磷酸，是应对当前核心疗法——PSMA靶向治疗——临床耐药挑战的关键所在。其在前列腺组织中独特的表达谱，为攻克肿瘤异质性与治疗耐受给予了差异化的解决路径，是驱动下一代联合治疗与序贯治疗的基石。 | |
| II. Description | |
| ACP3 LNCap clone FGC 细胞，在 LNCap clone FGC细胞的基础上，稳定表达ACP3。 | |
| III. Introduction | |
| Expressed gene: | ACP3 |
| Host Cell: | LNCap clone FGC |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+ 10% FBS + 5μg/ml Blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Binding Assay,FACS |
| IV. Representative Data | |
 Figure 1. Recombinant ACP3 LNCap clone FGC constitutively expressing ACP3. |
|
